These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparative evaluation of the methods for the study of synalbumin insulin antagonism. Bajaj JS; Bansal DD; Jindal HO; Garg SK Acta Diabetol Lat; 1974; 11(1):26-31. PubMed ID: 4440403 [No Abstract] [Full Text] [Related]
7. In vivo effects of the synalbumin insulin antagonist. Kammerer L; Vallance-Owen J Diabetologia; 1968 Dec; 4(6):336-8. PubMed ID: 5738374 [No Abstract] [Full Text] [Related]
8. The nature of human serum insulin-like activity (ILA)P Characterization of ILA in serum and serum fractions obtained by acid-ethanol extraction and adsorption chromatography. Poffenbarger PL; Ensinck JW; Hepp DK; Williams RH J Clin Invest; 1968 Feb; 47(2):301-20. PubMed ID: 4170389 [TBL] [Abstract][Full Text] [Related]
9. Studies of insulin antagonism. I. An artifactual antagonist to insulin and plasma nonsuppressible insulin-like activity occurring in preparation of "albumin". Ensinck JW; Poffenbarger PL; Hogan RA; Williams RH Diabetes; 1967 May; 16(5):289-301. PubMed ID: 6022555 [No Abstract] [Full Text] [Related]
10. Insulin-like activity and insulin-inhibitory effect of human albumin fractions studied with two biological test methods. Arvill A; Westberg G; Jonsson KA; Hood B; Ahrén K Diabetologia; 1966 Dec; 2(4):253-9. PubMed ID: 6005205 [No Abstract] [Full Text] [Related]
11. The properties of trichloracetic acid-ethanol extracts of human plasma. 2. Physical, chemical and immunological properties of the extracts. Cameron JS; Boyns DR; Jarrett RJ; Keen H Diabetologia; 1966 Sep; 2(2):91-5. PubMed ID: 6005202 [No Abstract] [Full Text] [Related]
12. The properties of trichloracetic acid-ethanol extracts of human plasma. 1. Bioassay and immunoassay of plasma and extracts. Cameron JS; Boyns DR; Jarrett RJ; Keen H Diabetologia; 1966 Sep; 2(2):86-90. PubMed ID: 6005215 [No Abstract] [Full Text] [Related]
13. [A new method of studying synalbumin insulin antagonist]. Kammerer L; Bretán M; Steingaszner O Orv Hetil; 1970 Jun; 111(25):1454-5. PubMed ID: 5454030 [No Abstract] [Full Text] [Related]
14. STUDIES OF THE INSULIN-INHIBITORY EFFECT OF HUMAN ALBUMIN FRACTIONS. ALP H; RECANT L J Clin Invest; 1965 May; 44(5):870-82. PubMed ID: 14276144 [No Abstract] [Full Text] [Related]
15. Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus. Davidson MB; Poffenbarger PL Metabolism; 1970 Sep; 19(9):668-86. PubMed ID: 4918251 [No Abstract] [Full Text] [Related]
16. Effects of the synalbumin insulin antagonist in vivo; its examination with a new method. Kammerer L; Bretán M; Steingaszner O Diabetologia; 1970 Oct; 6(5):473-4. PubMed ID: 5474812 [No Abstract] [Full Text] [Related]
17. Diabetic neuropathy--clinical and electrophysiological study in synalbumin positive and synalbumin negative subjects. Chopra JS; Connon JJ; Banerji NK Diabetologia; 1969 Dec; 5(6):413-5. PubMed ID: 5372894 [No Abstract] [Full Text] [Related]
18. To the editor: role of synalbumin insulin antagonist in the pathogenesis of diabetes mellitus. Vallance-Owen J; Bajaj JS Metabolism; 1971 May; 20(5):521-7. PubMed ID: 5580875 [No Abstract] [Full Text] [Related]
20. The inhibitory effect of a human serum albumin fraction on insulin activity. Koyama T; Miyamura K; Mizoguchi T Wakayama Med Rep; 1968 Mar; 12(4):193-204. PubMed ID: 5659919 [No Abstract] [Full Text] [Related] [Next] [New Search]